Investor relations

Invest in progress

Aquilon Pharmaceuticals aims to improve the efficacy of inhaled drugs by making existing drugs inhalable through the most patient friendly device platforms.

With your support, we are confident that we can continue to drive meaningful progress in the field of biotechnology and deliver significant value to our shareholders.

Investor relations chart

Interested in exploring the opportunities for investment in our company?